Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Kadmon Holdings Llc (KDMN)

4.85   -0.12 (-2.41%) 01-20 23:18
Open: 4.95 Pre. Close: 4.97
High: 5.08 Low: 4.81
Volume: 2,494,357 Market Cap: 832M
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. Its lead product candidates include KD025, an orally administered selective inhibitor of the rho-associated coiled-coil kinase 2, which is in Phase II clinical trial for the treatment of chronic graft-versus-host and fibrotic diseases; KD045, an oral inhibitor of ROCK for the treatment of fibrotic diseases; and KD033, an anti-PD-L1/IL-15 fusion protein for the treatment of cancer. The company also engages in developing Tesevatinib to treat autosomal dominant polycystic kidney disease; ribavirin, a nucleoside Inhibitor to treat hepatitis; and CLOVIQUE, a trientine hydrochloride capsules for the treatment of Wilson's disease. Kadmon Holdings, Inc. has strategic collaborations and license agreements with Nano Terra, Inc. and Dyax Corp. The company was founded in 2010 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.084 - 5.11 5.11 - 5.126
Low: 4.751 - 4.784 4.784 - 4.805
Close: 4.802 - 4.852 4.852 - 4.884

Technical analysis

as of: 2021-01-20 4:49:10 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 6.04     One year: 7.05
Support: Support1: 4.34    Support2: 3.83
Resistance: Resistance1: 5.17    Resistance2: 6.04
Pivot: 4.27
Moving Average: MA(5): 4.74     MA(20): 4.30
MA(100): 4.06     MA(250): 4.22
MACD: MACD(12,26): 0.15     Signal(9): 0.06
Stochastic oscillator: %K(14,3): 79.43     %D(3): 82.29
RSI: RSI(14): 64.37
52-week: High: 5.50  Low: 2.30  Change(%): 8.3
Average Vol(K): 3-Month: 255347  10-Days: 422410

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
KDMN has closed below upper band by 11.1%. Bollinger Bands are 81% wider than normal. The large width of the bands suggest high volatility as compared to KDMN's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Fri, 15 Jan 2021
Steven Cohen Boosts Kadmon Holdings Stake - Yahoo Finance

Fri, 15 Jan 2021
Brokerages Anticipate Kadmon Holdings, Inc. (NASDAQ:KDMN) Will Announce Quarterly Sales of $490,000.00 - MarketBeat

Mon, 30 Nov 2020
Kadmon Holdings Inc (KDMN) Stock: Buy, Hold, or Sell? - InvestorsObserver

Fri, 20 Nov 2020
Is Kadmon Holdings Inc (KDMN) a Stock to Watch This Week? - InvestorsObserver

Mon, 09 Nov 2020
What is the Forecast Price for Kadmon Holdings Inc (KDMN) Stock? - InvestorsObserver

Mon, 26 Oct 2020
Kadmon Holdings (NYSE:KDMN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 172
Shares Float (M) 133
% Held by Insiders 0.14
% Held by Institutions 96.54
Shares Short (K) 27,640
Shares Short P. Month (K) 29,460

Stock Financials

EPS -0.593
EPS Est This Year -1.550
EPS Est Next Year -1.750
Book Value (p.s.) 0.570
Profit Margin
Operating Margin -739.60
Return on Assets (ttm) -32.4
Return on Equity (ttm) -83.8
Qtrly Rev. Growth 209.5
Gross Profit (p.s.) 0.022
Sales Per Share 0.070
EBITDA (p.s.) -0.513
Qtrly Earnings Growth
Operating Cash Flow (M) -77
Levered Free Cash Flow (M) -42

Stock Valuations

PE Ratio -8.18
PEG Ratio
Price to Book value 8.51
Price to Sales 68.92
Price to Cash Flow -10.77

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.